跳至主要内容
临床试验/NL-OMON21654
NL-OMON21654招募中不适用

DUrable Polymer-based STent CHallenge of Promus ElemEnt versus ReSolute Integrity (DUTCH PEERS): Randomized Multicenter Trial in All-Comers Population Treated Within Eastern NeThErlands-2 (TWENTE-2).

Medisch Spectrum Twente0 个研究点目标入组 1,788 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,788

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Minimum age of 18 years;
  • 2. Coronary artery disease and lesion(s) eligable for treatment with drug eluting stents according to clinical guidelines and/or the operators’ judgement;

排除标准

  • 1. Participation in another randomized drug or device study before reaching primary endpoint;
  • 2. Planned surgery within 6 months of PCI unless dual antiplatelet therapy is maintained throughout the peri-surgical period;

研究者

相似试验